We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$682M
AUM Growth
-$12.7M
Cap. Flow
-$20.5M
Cap. Flow %
-3%
Top 10 Hldgs %
81.81%
Holding
45
New
Increased
4
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.42M
2
MBI icon
MBIA
MBI
+$936K
3
VRAY
ViewRay, Inc.
VRAY
+$443K
4
VZ icon
Verizon
VZ
+$1.15K

Top Sells

Rank Stock Value
1
AGO icon
Assured Guaranty
AGO
+$5.59M
2
BP icon
BP
BP
+$4.35M
3
MRK icon
Merck
MRK
+$2.6M
4
PTEN icon
Patterson-UTI
PTEN
+$2.46M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.97M

Sector Composition

Rank Sector Weight
1 Healthcare 34.82%
2 Financials 34.1%
3 Energy 16.56%
4 Technology 6.63%
5 Consumer Staples 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$315B
$74.8M 10.97%
648,671
-22,933
-3% -$2.6M
FLG
2
Flagstar Bank National Association
FLG
$6.21B
$71.4M 10.47%
2,117,557
-12,158
-0.6% -$369K
BP icon
3
BP
BP
$108B
$65M 9.53%
1,842,491
-117,466
-6% -$4.35M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$61.3M 8.99%
871,244
-29,312
-3% -$1.97M
AGO icon
5
Assured Guaranty
AGO
$3.76B
$58M 8.5%
1,038,934
-105,219
-9% -$5.59M
C icon
6
Citigroup
C
$217B
$55.6M 8.15%
1,206,806
-10,747
-0.9% -$503K
PTEN icon
7
Patterson-UTI
PTEN
$3.8B
$45.9M 6.73%
3,835,467
-217,820
-5% -$2.46M
GSK icon
8
GSK
GSK
$104B
$45M 6.6%
1,263,458
-14,018
-1% -$503K
MBI icon
9
MBIA
MBI
$333M
$41.8M 6.13%
4,838,495
+103,933
+2% +$936K
PFE icon
10
Pfizer
PFE
$143B
$39.1M 5.73%
1,066,091
+36,429
+4% +$1.42M
VOXX
11
DELISTED
VOXX International Corporation Class A
VOXX
$37.2M 5.45%
2,924,166
-58,850
-2% -$696K
SEB icon
12
Seaboard Corp
SEB
$4.34B
$34M 4.99%
9,560
HLN icon
13
Haleon
HLN
$44.5B
$10.6M 1.56%
1,270,438
-110,834
-8% -$946K
IDT icon
14
IDT Corp
IDT
$1.57B
$9.13M 1.34%
353,115
-13,116
-4% -$405K
BB icon
15
BlackBerry
BB
$5.27B
$7.78M 1.14%
1,406,245
-6,700
-0.5% -$32.5K
GNE icon
16
Genie Energy
GNE
$369M
$4.27M 0.63%
302,064
-8,498
-3% -$126K
WBS icon
17
Webster Financial
WBS
$12.3B
$4.02M 0.59%
106,412
-6,609
-6% -$244K
HOLX
18
DELISTED
Hologic
HOLX
$2.43M 0.36%
30,035
NVS icon
19
Novartis
NVS
$293B
$2.18M 0.32%
21,578
XOM icon
20
ExxonMobil
XOM
$611B
$1.5M 0.22%
13,955
-300
-2% -$32.7K
OGN icon
21
Organon & Co
OGN
$3.55B
$1.24M 0.18%
59,798
-1,821
-3% -$39.6K
BAC icon
22
Bank of America
BAC
$430B
$932K 0.14%
32,481
-7,258
-18% -$207K
TPHS
23
DELISTED
Trinity Place Holdings Inc.com
TPHS
$806K 0.12%
1,492,415
VRAY
24
DELISTED
ViewRay, Inc.
VRAY
$721K 0.11%
2,048,547
+427,750
+26% +$443K
VTRS icon
25
Viatris
VTRS
$20.1B
$716K 0.11%
71,782
-1,855
-3% -$17.7K

Similar funds

Kahn Brothers Group's Q2 2023 Portfolio in Review

As of Q2 2023, Kahn Brothers Group held 45 positions worth $682M, down 1.8% from $695M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Kahn Brothers Group opened no new positions and exited 2, leaving the 45-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Financials and Energy.

  • Kahn Brothers Group added most to Pfizer in Q2 2023, an estimated $1.42M increase.
  • Kahn Brothers Group's biggest Q2 2023 reduction was Assured Guaranty, cutting an estimated $5.59M.
  • Kahn Brothers Group fully exited Berkshire Hathaway Class B in Q2 2023, selling an estimated $959K.
  • Kahn Brothers Group's ten largest holdings make up 82% of its $682M portfolio in Q2 2023.
  • Kahn Brothers Group opened 0 new positions and closed 2 in Q2 2023.
  • Kahn Brothers Group's portfolio value fell 1.8% quarter-over-quarter to $682M.

Based on Kahn Brothers Group's 13F filing for Q2 2023, filed 9 Aug 2023.